Anzeige
Mehr »
Sonntag, 24.08.2025 - Börsentäglich über 12.000 News

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
ACCESS Newswire
263 Leser
Artikel bewerten:
(1)

ZetrOZ Systems is Helping Americans Get Back to Work

TRUMBULL, CT / ACCESSWIRE / August 17, 2021 / As America gets back to work, businesses are placing a higher premium on the health and wellbeing of their employees. ZetrOZ Systems, developers of the Sustained Acoustic Medicine (sam®) wearable pain relief ultrasound device, is helping employers minimize the impact and likelihood of workplace injuries.

Numerous studies have demonstrated the seasonal timing of work-related injuries, and employers must be quick to provide effective solutions to help preserve the health and wellness of their workforce as markets see an increased rise in consumer demand.

"Workplace injuries can have a significant impact on an organization's efficiency, and powerful narcotics are too often used to treat injuries which might not otherwise require them," said Dr. George Lewis, founder and CEO of ZetrOz Systems. "sam® is a safer, less invasive, and more effective treatment than surgery and narcotics, which include their own risks and potential for long-term complications."

ZetrOZ Systems's sam® is the only FDA-cleared long duration ultrasound device and in more than 40 peer-reviewed studies, it has been shown to be an effective treatment to relieve pain, restore function and return patients to work, sports and daily activities.

The most common workplace injuries include shoulder and lower-back injuries, as a result of improper lifting technique or routine overuse. When workers sustain these types of injuries, they're often too eager to return to work and don't allow their body enough time to properly heal, Lewis said.

Inadequate recovery time keeps workers off the job for longer than they have to be.

sam® was designed for easy, long term home use. Its low-intensity ultrasound therapy for home use treats injuries at the depth the size of a grapefruit, inhibiting inflammation and increasing the rate of tissue regeneration, angiogenesis, and nutrient exchange.

Employers quick to deploy sam® for injured employees can reduce healthcare costs and lost productivity by reducing recovery time through a more effective and less invasive treatment option that requires no surgery or narcotics.

Organizations are putting a higher priority on hiring and retaining their existing talent, and sam® is an effective tool for employers to keep employees on the job and more resilient to injury. As employers respond to a never-before-seen challenge in finding and retaining employees, keeping workers healthy is crucial.

For more information, visit samrecover.com or ZetrOZ.com to learn more.

About ZetrOZ Systems:
ZetrOZ Systems is an FDA cGMP and ISO 13585 medical technology company headquartered in the southern coastal region of Connecticut. The organization also has manufacturing facilities across the United States. ZetrOZ Systems produced UltrOZ®, sam®Sport and sam®Pro 2.0 to provide safe and effective treatment options for prevalent conditions such as arthritis. Learn more at zetroz.com and samrecover.com.

Media Contact:

Bianca D'Angelo
(203)577-7588 (Direct)
bianca@newswire.com
www.Newswire.com

Related Images

SOURCE: ZetrOZ Systems



View source version on accesswire.com:
https://www.accesswire.com/659923/ZetrOZ-Systems-is-Helping-Americans-Get-Back-to-Work

© 2021 ACCESS Newswire
Zeitenwende! 3 Uranaktien vor der Neubewertung
Ende Mai leitete US-Präsident Donald Trump mit der Unterzeichnung mehrerer Dekrete eine weitreichende Wende in der amerikanischen Energiepolitik ein. Im Fokus: der beschleunigte Ausbau der Kernenergie.

Mit einem umfassenden Maßnahmenpaket sollen Genehmigungsprozesse reformiert, kleinere Reaktoren gefördert und der Anteil von Atomstrom in den USA massiv gesteigert werden. Auslöser ist der explodierende Energiebedarf durch KI-Rechenzentren, der eine stabile, CO₂-arme Grundlastversorgung zwingend notwendig macht.

In unserem kostenlosen Spezialreport erfahren Sie, welche 3 Unternehmen jetzt im Zentrum dieser energiepolitischen Neuausrichtung stehen, und wer vom kommenden Boom der Nuklearindustrie besonders profitieren könnte.

Holen Sie sich den neuesten Report! Verpassen Sie nicht, welche Aktien besonders von der Energiewende in den USA profitieren dürften, und laden Sie sich das Gratis-PDF jetzt kostenlos herunter.

Dieses exklusive Angebot gilt aber nur für kurze Zeit! Daher jetzt downloaden!
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.